(Q36271849)

13 August 2017

1 reference

title

Latent autoimmune diabetes in adults (LADA) should be less latent (English)

1 reference

13 August 2017

3

Greenbaum CJ

1 reference

13 August 2017

4

Palmer JP

1 reference

13 August 2017

Fourlanos S

1

1 reference

13 August 2017

Dotta F

2

1 reference

13 August 2017

Rolandsson O

5

1 reference

13 August 2017

Colman PG

6

1 reference

13 August 2017

Harrison LC

7

1 reference

13 August 2017

publication date

29 September 2005

1 reference

13 August 2017

1 reference

13 August 2017

volume

48

1 reference

13 August 2017

issue

11

1 reference

13 August 2017

page(s)

2206-2212

1 reference

Insulin and glucagon secretion in patients with slowly progressing autoimmune diabetes (LADA).

13 August 2017

cites work

1 reference

12 December 2020

Phenotypic characteristics of GAD antibody-positive recently diagnosed patients with type 2 diabetes in North America and Europe

1 reference

12 December 2020

Autoimmune thyroid disease: propagation and progression

1 reference

12 December 2020

Unique epitopes of glutamic acid decarboxylase autoantibodies in slowly progressive type 1 diabetes

1 reference

12 December 2020

Autoantibodies to glutamic acid decarboxylase in diabetic patients from a multi-ethnic Australian community: the Fremantle Diabetes Study

1 reference

12 December 2020

Thyroid function, morphology and autoimmunity in young patients with insulin-dependent diabetes mellitus

1 reference

12 December 2020

Variable number of tandem repeats of the insulin gene determines susceptibility to latent autoimmune diabetes in adults

1 reference

12 December 2020

Age-dependent HLA genetic heterogeneity of type 1 insulin-dependent diabetes mellitus

1 reference

12 December 2020

The Finnish Diabetes Prevention Study.

1 reference

12 December 2020

Distinct cytoplasmic islet cell antibodies with different risks for type 1 (insulin-dependent) diabetes mellitus

1 reference

12 December 2020

Differences in the genetic background of latent autoimmune diabetes in adults (LADA) and type 1 diabetes mellitus

1 reference

12 December 2020

Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus

1 reference

12 December 2020

Type I diabetes masquerading as type II diabetes. Possible implications for prevention and treatment

1 reference

12 December 2020

Prognostically significant heterogeneity of cytoplasmic islet cell antibodies in relatives of patients with type I diabetes

1 reference

12 December 2020

Type 1 1/2 diabetes: myth or reality?

1 reference

12 December 2020

Chronic complications in patients with slowly progressing autoimmune type 1 diabetes (LADA).

1 reference

12 December 2020

UKPDS 25: autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes

1 reference

12 December 2020

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group

1 reference

12 December 2020

Slow metabolic deterioration towards diabetes in islet cell antibody positive patients with autoimmune polyendocrine disease

1 reference

12 December 2020

Autoimmune diabetes not requiring insulin at diagnosis (latent autoimmune diabetes of the adult): definition, characterization, and potential prevention

1 reference

12 December 2020

Insulin requirement in non-insulin-dependent diabetes mellitus: relation to simple tests of islet B-cell function and insulin sensitivity.

1 reference

12 December 2020

Two distinct MICA gene markers discriminate major autoimmune diabetes types

1 reference

12 December 2020

Cellular immune responses to human islet proteins in antibody-positive type 2 diabetic patients.

1 reference

12 December 2020

Multicenter prevention trial of slowly progressive type 1 diabetes with small dose of insulin (the Tokyo study): preliminary report

1 reference

12 December 2020

HLA antigens and age at diagnosis of insulin-dependent diabetes mellitus

1 reference

12 December 2020

Gliadin, endomysial and thyroid antibodies in patients with latent autoimmune diabetes of adults (LADA).

1 reference

12 December 2020

Prevalence of coeliac disease and longitudinal follow-up of antigliadin antibody status in children and adolescents with type 1 diabetes mellitus

1 reference

12 December 2020

"Lady-like": is there a latent autoimmune diabetes in the young?

1 reference

12 December 2020

Impaired insulin secretion in non-diabetic offspring of probands with latent autoimmune diabetes mellitus in adults

1 reference

12 December 2020

Effect of intensive therapy on residual beta-cell function in patients with type 1 diabetes in the diabetes control and complications trial. A randomized, controlled trial. The Diabetes Control and Complications Trial Research Group

1 reference

12 December 2020

Clinical and genetic characteristics of type 2 diabetes with and without GAD antibodies.

1 reference

12 December 2020

Combined use of autoantibodies (IA-2 autoantibody, GAD autoantibody, insulin autoantibody, cytoplasmic islet cell antibodies) in type 1 diabetes: Combinatorial Islet Autoantibody Workshop

1 reference

12 December 2020

Diabetic neuropathy in patients with "latent autoimmune diabetes of the adults" (LADA) compared with patients with type 1 and type 2 diabetes

1 reference

12 December 2020

Susceptibility to human type 1 diabetes at IDDM2 is determined by tandem repeat variation at the insulin gene minisatellite locus

1 reference

12 December 2020

Beta-cell function in relation to islet cell antibodies during the first 3 yr after clinical diagnosis of diabetes in type II diabetic patients.

1 reference

12 December 2020

Frequency of Hashimoto's thyroiditis in children with type 1 diabetes mellitus

1 reference

12 December 2020

What's in a name: latent autoimmune diabetes of adults, type 1.5, adult-onset, and type 1 diabetes

1 reference

12 December 2020

T-cell insulitis found in anti-GAD65+ diabetes with residual beta-cell function. A case report

1 reference

12 December 2020

Polymorphism of INS VNTR is associated with glutamic acid decarboxylase antibodies and postprandial C-peptide in patients with onset of diabetes after 35 years of age.

1 reference

12 December 2020

A comparison of childhood and adult type I diabetes mellitus

1 reference

12 December 2020

Quantitative assay using recombinant human islet glutamic acid decarboxylase (GAD65) shows that 64K autoantibody positivity at onset predicts diabetes type

1 reference

12 December 2020

The insulin gene is transcribed in the human thymus and transcription levels correlated with allelic variation at the INS VNTR-IDDM2 susceptibility locus for type 1 diabetes.

1 reference

12 December 2020

Small doses of subcutaneous insulin as a strategy for preventing slowly progressive beta-cell failure in islet cell antibody-positive patients with clinical features of NIDDM.

1 reference

12 December 2020

Antibodies to glutamic acid decarboxylase reveal latent autoimmune diabetes mellitus in adults with a non-insulin-dependent onset of disease

1 reference

12 December 2020

Increased risk for endocrine autoimmunity in Italian type 2 diabetic patients with GAD65 autoantibodies

1 reference

12 December 2020

CTLA-4 gene polymorphism contributes to the genetic risk for latent autoimmune diabetes in adults

1 reference

12 December 2020

Insulin expression in human thymus is modulated by INS VNTR alleles at the IDDM2 locus.

1 reference

12 December 2020

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

1 reference

12 December 2020

Diabetes in the parents of children with Type I diabetes

1 reference

12 December 2020

HLA in Czech adult patients with autoimmune diabetes mellitus: comparison with Czech children with type 1 diabetes and patients with type 2 diabetes

1 reference

12 December 2020

Risk assessment, prediction and prevention of type 1 diabetes

1 reference

12 December 2020

Clinical, autoimmune, and genetic characteristics of adult-onset diabetic patients with GAD autoantibodies in Japan (Ehime Study).

1 reference

12 December 2020

Insulin resistance in latent autoimmune diabetes of adulthood

1 reference

12 December 2020

1 reference

12 December 2020

Prediction of IDDM in the general population: strategies based on combinations of autoantibody markers

1 reference

12 December 2020

Glutamic acid decarboxylase antibodies (GADA) is the most important factor for prediction of insulin therapy within 3 years in young adult diabetic patients not classified as Type 1 diabetes on clinical grounds

1 reference

12 December 2020

High-sensitivity C-reactive protein and cardiovascular risk: rationale for screening and primary prevention

1 reference

12 December 2020

High levels of antigen-specific islet antibodies predict future beta-cell failure in patients with onset of diabetes in adult age.

1 reference

12 December 2020

10.1007/S00125-005-1960-7

Identifiers

DOI

1 reference

13 August 2017

1 reference